BRIEF-PSivida says 2nd phase 3 trial of Medidur met target enrollment
October 04, 2016 at 07:16 AM EDT
* PSivida corp says filing for EU registration remains on track for first calendar quarter of 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.